3 Data Linkage Use Cases To Future Proof Your Clinical Trials

Access to compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes. But silos between clinical trial data (CTD) and real-world data (RWD) make it difficult to fully understand what happens to patients outside of a clinical trial.

Historically, the disconnect between CTD and RWD stems from patient privacy concerns. However, this evidence gap delays access to critical efficacy, effectiveness, safety, and utilization data—ultimately becoming a detriment to patients. For example, the fragmented nature of healthcare data has prevented a rapid and clear analysis into the impact of “long” COVID-19, as well as the actual healthcare journey and impact of Vaping-Associated Pulmonary Injury (VAPI).